|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Respiratory, weight loss, exercise intolerance, heart failure
|
Ivermectin, milbemycin, selamectin, moxidectin
|
Melarsomine, doxycycline, symptomatic treatment
|
Moxidectina, ivermectin + doxycycline, milbemycin
|
|
|
|
|
|
|
Respiratory, vomiting, sudden death, heart failure
|
Ivermectin, milbemycin, selamectin, moxidectin
|
Symptomatic treatment;, doxycycline + ML, worm extraction
|
|
|
|
|
|
|
|
Heart failure, respiratory, sudden death, heart failure
|
Topical imidacloprid-moxidectin product labeled for cats and ferrets
This product should be administered monthly at the recommended minimum dosage of imidacloprid (20 mg/kg), and moxidectin (2 mg/kg), by topical administration, regardless of indoor/outdoor status.
|
Symptomatic treatment (including corticosteroids) Possibly topical imidacloprid-moxidectin labeled for cats and ferrets
|
|
aImidacloprid-moxidectin is the only approved microfilaricide.
* = rarely useful; ** = somewhat useful; *** = moderately useful; **** = often useful; ***** = excellent test; Ag = antigen; Ab = antibody; # = Ab-positive does not prove mature infection, only exposure/abbreviated infection; MPA = main pulmonary artery enlargement; PA = pulmonary artery enlargement; PTE = pulmonary thrombus/thromboembolus; PIE = pulmonary infiltrate with eosinophils; ML = macrocyclic lactone (macrolide); RH = right heart enlargement; NA = not applicable
Adapted from McCall, JW. Clin Tech Small Anim Pract. 1998;13(2):112.
|
